Life Sciences Times

TreeFrog Therapeutics Leases 13,488 Square Feet at Cambridgeport Labs

January 6, 2025

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

December 18, 2024

Tasca Therapeutics Launches with $52 Million Series A Financing

December 10, 2024

THIS WEEK'S STORIES

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

January 8, 2025

Transcarent To Acquire Accolade

January 8, 2025

Royal Orthopaedic Hospital Leverages VitVio’s AI-powered Platform to Increase the Efficiency and Safety in Operating Rooms

January 8, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Transcarent To Acquire Accolade

Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer

Royal Orthopaedic Hospital Leverages VitVio’s AI-powered Platform to Increase the Efficiency and Safety in Operating Rooms

EDITOR PICKS

TreeFrog Therapeutics Leases 13,488 Square Feet at Cambridgeport Labs

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Tasca Therapeutics Launches with $52 Million Series A Financing

THIS WEEK'S STORIES

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Transcarent To Acquire Accolade

Royal Orthopaedic Hospital Leverages VitVio’s AI-powered Platform to Increase the Efficiency and Safety in Operating Rooms

POPULAR CATEGORY

ABOUT US

FOLLOW US